Log in

006120 SK Discovery Co. Ltd. KRX · South Korea

SK Discovery Co. (006120) news

SK Discovery Co. Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 006120, recorded under South Korea. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest SK Discovery Co. news

We have not published a story on SK Discovery Co. yet. When there is news, it will appear here.

Questions about SK Discovery Co.

What is the ticker symbol of SK Discovery Co.?

SK Discovery Co. Ltd. trades under the ticker 006120 on KRX.

Where is SK Discovery Co. listed?

SK Discovery Co. Ltd. is listed on KRX. Our directory also records these other listings: KRX:006125.

Which country or territory is SK Discovery Co. listed under?

Our directory records SK Discovery Co. Ltd. under South Korea.

What does SK Discovery Co. do?

Our directory classifies SK Discovery Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of SK Discovery Co.?

The ISIN recorded for SK Discovery Co. Ltd. is KR7006120000.

Does aibio.space cover SK Discovery Co.?

aibio.space lists SK Discovery Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to SK Discovery Co.?

Companies in our directory listed in the same country and business area as SK Discovery Co.: HYUNDAI BIOSCIENCE CO. LTD., GC, WooGene B&G Co., Daewon Pharmaceutical Co., KOREA UNITED PHARM, INC., Hana Pharm Co..

Investor discussion: SK Discovery Co.

Members talk about SK Discovery Co. (006120). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:006120 on TradingView.

Listing details

SK Discovery Co. Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 006120, recorded under South Korea. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
SK Discovery Co. Ltd.
Ticker
006120
Listing
KRX
Country or territory
South Korea
Business scope
Pharmaceuticals: Major
ISIN
KR7006120000
Other listed symbols
KRX:006125
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.